Ligand validation:4GYC

RET: RETINAL

RET is a Ligand Of Interest in 4GYC designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4GYC_RET_A_301	77%	13%	0.121	0.96	2.08	1.93	6	7	1	0	100%	0.9524
7PNC_RET_A_301	95%	72%	0.055	0.958	0.76	0.35	1	-	0	0	100%	0.9524
3QAP_RET_A_240	84%	9%	0.097	0.966	2.61	1.82	13	9	1	0	95%	0.9524
1H68_RET_A_300	71%	31%	0.139	0.96	1.61	1.14	4	4	0	0	100%	0.9524
8QQO_RET_A_300	70%	47%	0.143	0.962	1.16	0.88	2	-	1	0	100%	0.7524
5JJN_RET_A_310	63%	0%	0.153	0.95	7.02	3.8	10	18	2	0	100%	0.9524
3UTY_RET_A_301	100%	5%	0.028	0.992	2.48	2.7	6	12	2	0	100%	0.9524
3UTX_RET_B_301	100%	6%	0.042	0.988	2.42	2.7	5	12	4	0	100%	0.9524
7XJE_RET_A_301	99%	6%	0.048	0.983	1.99	2.98	4	14	1	0	100%	0.9524
5G28_RET_A_1268	97%	23%	0.051	0.968	1.29	1.84	3	5	0	0	100%	0.9524
7XJC_RET_A_301	97%	10%	0.067	0.98	1.93	2.43	2	14	0	0	100%	0.7752

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.